Alessandro P. Delitala*, Giuseppe Fanciulli, Giovanni M. Pes, Margherita Maioli and Giuseppe Delitala Pages 56 - 62 ( 7 )
Metabolic syndrome is a clustering of various metabolic parameters, which include diabetes, low high-density lipoprotein cholesterol, elevated triglycerides, abdominal obesity, and hypertension. It has merged as a worldwide epidemic and a major public health care concern. However, due to the different criteria used for the assessment, the frequency of metabolic syndrome in the general population is variable but it is more common in the older people. Metabolic syndrome is closely linked to cardiovascular risk and increases cardiovascular outcomes and all-cause mortality.Recent evidences showed that alterations of the thyroid function could have an impact on the components of the metabolic syndrome, suggesting that thyroid hormones have a variety of effects on energy homeostasis, lipid and glucose metabolism, and blood pressure. In this review, we summarize available data on the action of thyroid hormone on the components of metabolic syndrome.
Metabolic syndrome, cardiovascular risk, obesity, thyroid hormone, subclinical hypothyroidism, obesity.
Azienda Ospedaliero- Universitaria (AOU) di Sassari, Clinica Medica, Viale San Pietro 8 Sassari 07100, Department of Clinical and Experimental Medicine, University of Sassari – Azienda Ospedaliero Universitaria di Sassari, Viale San Pietro 8, 07100 Sassari, Department of Clinical and Experimental Medicine, University of Sassari – Azienda Ospedaliero Universitaria di Sassari, Viale San Pietro 8, 07100 Sassari, National Institute of Biostructures and Biosystems at the Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola - Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, University of Sassari – Azienda Ospedaliero Universitaria di Sassari - Department of Clinical and Experimental Medicine Sassari